258 related articles for article (PubMed ID: 18033304)
1. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone.
Aghai ZH; Faqiri S; Saslow JG; Nakhla T; Farhath S; Kumar A; Eydelman R; Strande L; Stahl G; Leone P; Bhandari V
J Perinatol; 2008 Feb; 28(2):149-55. PubMed ID: 18033304
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin1 in tracheal aspirate leukocytes: possible role in the development of bronchopulmonary dysplasia in premature infants.
Mody K; Saslow JG; Kathiravan S; Eydelman R; Bhat V; Stahl GE; Pyon K; Bhandari V; Aghai ZH
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1483-7. PubMed ID: 22272724
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ and IP-10 in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia.
Aghai ZH; Saslow JG; Mody K; Eydelman R; Bhat V; Stahl G; Pyon K; Bhandari V
Pediatr Pulmonol; 2013 Jan; 48(1):8-13. PubMed ID: 22431160
[TBL] [Abstract][Full Text] [Related]
4. Airway angiopoietin-2 in ventilated very preterm infants: association with prenatal factors and neonatal outcome.
Thomas W; Seidenspinner S; Kramer BW; Wirbelauer J; Kawczyńska-Leda N; Szymankiewicz M; Speer CP
Pediatr Pulmonol; 2011 Aug; 46(8):777-84. PubMed ID: 21337734
[TBL] [Abstract][Full Text] [Related]
5. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
[TBL] [Abstract][Full Text] [Related]
6. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
[TBL] [Abstract][Full Text] [Related]
7. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
Farhath S; He Z; Nakhla T; Saslow J; Soundar S; Camacho J; Stahl G; Shaffer S; Mehta DI; Aghai ZH
Pediatrics; 2008 Feb; 121(2):e253-9. PubMed ID: 18245400
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary Dysplasia.
Baier RJ; Loggins J; Kruger TE
BMC Pediatr; 2003 Aug; 3():8. PubMed ID: 12925236
[TBL] [Abstract][Full Text] [Related]
9. High-mobility group box-1 protein in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia and steroid therapy.
Aghai ZH; Saslow JG; Meniru C; Porter C; Eydelman R; Bhat V; Stahl G; Sannoh S; Pyon K; Hewitt C; Bhandari V
J Perinatol; 2010 Sep; 30(9):610-5. PubMed ID: 20182437
[TBL] [Abstract][Full Text] [Related]
10. Exposure to oxygen and head growth in infants with bronchopulmonary dysplasia.
Nesterenko TH; Nolan B; Hammad TA; Aly H
Am J Perinatol; 2008 Apr; 25(4):251-4. PubMed ID: 18548401
[TBL] [Abstract][Full Text] [Related]
11. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
Yoder BA; Harrison M; Clark RH
Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 -1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants.
Yanamandra K; Boggs P; Loggins J; Baier RJ
Pediatr Pulmonol; 2005 May; 39(5):426-32. PubMed ID: 15678510
[TBL] [Abstract][Full Text] [Related]
13. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia.
Watterberg KL; Scott SM
Pediatrics; 1995 Jan; 95(1):120-5. PubMed ID: 7770288
[TBL] [Abstract][Full Text] [Related]
14. Increased interleukin-8 and monocyte chemoattractant protein-1 concentrations in mechanically ventilated preterm infants with pulmonary hemorrhage.
Baier RJ; Loggins J; Kruger TE
Pediatr Pulmonol; 2002 Aug; 34(2):131-7. PubMed ID: 12112780
[TBL] [Abstract][Full Text] [Related]
15. Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia.
Kewitz G; Wudel S; Hopp H; Hopfenmüller W; Vogel M; Roots I
J Perinat Med; 2008; 36(4):359-64. PubMed ID: 18598128
[TBL] [Abstract][Full Text] [Related]
16. PCO2 and room air saturation values in premature infants at risk for bronchopulmonary dysplasia.
Kaempf JW; Campbell B; Brown A; Bowers K; Gallegos R; Goldsmith JP
J Perinatol; 2008 Jan; 28(1):48-54. PubMed ID: 18033306
[TBL] [Abstract][Full Text] [Related]
17. Lower concentration of pulmonary hepatocyte growth factor is associated with more severe lung disease in preterm infants.
Lassus P; Heikkilä P; Andersson LC; von Boguslawski K; Andersson S
J Pediatr; 2003 Aug; 143(2):199-202. PubMed ID: 12970632
[TBL] [Abstract][Full Text] [Related]
18. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia.
Baier RJ; Majid A; Parupia H; Loggins J; Kruger TE
Pediatr Pulmonol; 2004 Feb; 37(2):137-48. PubMed ID: 14730659
[TBL] [Abstract][Full Text] [Related]
19. Impaired growth at birth and bronchopulmonary dysplasia classification: beyond small for gestational age.
Nyp MF; Taylor JB; Norberg M; Truog WE
Am J Perinatol; 2015 Jan; 32(1):75-82. PubMed ID: 24839148
[TBL] [Abstract][Full Text] [Related]
20. Is the new definition of bronchopulmonary dysplasia more useful?
Sahni R; Ammari A; Suri MS; Milisavljevic V; Ohira-Kist K; Wung JT; Polin RA
J Perinatol; 2005 Jan; 25(1):41-6. PubMed ID: 15538399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
